You are here

FDA Perspective: NDA, Anda, Compounders- 503a and 503b, Inspections and Changes of Labelling

Author  Wiley A. Chambers II, MD
Meeting  2018 Annual Meeting
Session  SYM-307: #EyeConnect Live: Phake News Edition!
Date  April 17, 2018
Rate This Content
Total votes: 2
 

This presentation was recorded at the 2018 Annual Meeting.
View more from this session and browse all 2018 Annual Meeting presentations via Presentations On Demand.

About this Session

SYM-307: #EyeConnect Live: Phake News Edition!
Sponsored by the ASCRS EyeConnect Committee

Moderator: Michelle Akler, MD
Panelists: Yuri McKee, MD
  William G. Myers, MD
  John Odette, MD
  Michael Posner, MD